INSP250117C185000
- 0.40
- -0.35-46.67%
Inspire Medical Systems Newsroom
Analysts Are Bullish on These Healthcare Stocks: Inspire Medical Systems (INSP), UnitedHealth (UNH)
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Buy Rating
A Quick Look at Today's Ratings for Inspire Medical Systems(INSP.US), With a Forecast Between $230 to $270
Positive Growth Prospects Reinforce Buy Rating for Inspire Medical Systems
RBC Capital Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $260
BofA Securities Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $255
Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), Denali Therapeutics (DNLI) and Inspire Medical Systems (INSP)
Oppenheimer Maintains Inspire Medical Systems(INSP.US) With Hold Rating
Hold Rating on Inspire Medical Systems Amid FDA Approval of Tirzepatide for OSA
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Maintains Target Price $198
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Maintains Target Price $198
Inspire Medical Systems: Balancing Growth Prospects and Market Challenges – A Hold Rating by Larry Biegelsen
Inspire Medical Systems Analyst Ratings
BofA Securities Upgrades Inspire Medical Systems(INSP.US) to Buy Rating, Raises Target Price to $255
Inspire Medical Systems Maintains Strong Market Position Amidst LIVN's Aura6000 Uncertainties
Lake Street Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $270
A Quick Look at Today's Ratings for Inspire Medical Systems(INSP.US), With a Forecast Between $200 to $270
Inspire Medical Systems: Mixed Signals Lead to Hold Rating Amid Utilization and Competitive Challenges
Inspire Medical Systems Price Target Raised to $198.00/Share From $187.00 by Wells Fargo
A Quick Look at Today's Ratings for Inspire Medical Systems(INSP.US), With a Forecast Between $198 to $260